Intas Pharmaceuticals Limited Exemestane Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Exemestane Export Records India — #1 Exporter, 260 Shipments, $4.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Exemestane

India Pharmaceutical Trade Intelligence

$14.5M87 Suppliers57 CountriesHS 30049049

ExportsIndia → UNITED STATES39.3%India → BRAZIL12.2%

ImportsUNITED STATES → India$163.0K ITALY → India$146.4K

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: CARDINAL HEALTH

Intas Pharmaceuticals Limited — Exemestane Exporter #1 | $4.9M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Exemestane Exporter Profile

Indian Pharmaceutical Exporter · #1 for Exemestane · $4.9M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #1 Indian exporter of Exemestane with $4.9M in export value and 260 verified shipments. Intas Pharmaceuticals Limited holds a 31.1% market share in Exemestane exports across 21 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Exemestane Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Exemestane export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Exemestane?

Country	Value	Shipments	Share
NETHERLANDS	$1.7M	78	39.5%
GERMANY	$740.7K	25	17.6%
HUNGARY	$322.6K	8	7.7%
UNITED KINGDOM	$282.0K	15

Who Are the Top Buyers of Exemestane from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	UNITED KINGDOM	$681.4K	51
BROCACEF NL HUB	NETHERLANDS	$670.4K	20
FIEGE HEALTHCARE LOGISTICS GMBH	GERMANY	$558.2K	19
EUROPEAN PHARMAHUB	HUNGARY	$272.6K	7
ACCORD UK	UNITED KINGDOM	$217.7K	7
BROCACEF NL : HUB	NETHERLANDS	$202.5K	12
ACCORD HEALTHCARE SINGLE MEMBER SA	GREECE	$194.9K	7
PHARMA LOGISTIK AUSTRIA GMBH	ITALY	$162.9K	24
BROCACEF NL:HUB	NETHERLANDS	$137.4K	5
BROCACEF NL : DUTCH	NETHERLANDS	$94.2K	4

Intas Pharmaceuticals Limited supplies Exemestane to 40 buyers globally. The largest buyer is TO THE ORDER (UNITED KINGDOM), followed by BROCACEF NL HUB (NETHERLANDS) and FIEGE HEALTHCARE LOGISTICS GMBH (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Exemestane Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUGS & MEDI EXEMESTANE 25MG 10X1	$396.1K	13
PHARMA DRUG&MED:EXEMESTANE 25MG 10X10T G	$351.8K	8
PHARMA DRUG&MED:EXEMESTANE 25MG 3X10T G1	$192.6K	11
PHR DRUGS & MEDI EXEMESTANE 25MG 10T G1(ACCORD-EUROPE EACH FILM COATED TABLETSCONTAINS EXEMESTANE 25MG	$131.9K	3
PHARMA DRUGS & MEDI EXEMESTANE 25MG 3X10	$123.2K	8
PHARMA DRUGS & MEDI EXEMESTANE TAB 25MG 3X10T G1ACCORD-UK AS PER DOCUMENT	$119.3K	3
PH.DRU. & MED.: EXEMESTAN SANDOZ 25MG TABLETS (EXEMESTANE TABLETS 25MG EACH TABLET CONT: EXEMESTANE 25MG) [3885X6X15T] PNOS	$116.6K	3
PHARMA DRUG&MED: EXEMESTANE 25MG EACH TABLET CONTAINS: EXEMESTANE...25MGNOS	$106.1K	3
PHARMA DRUGS MEDI EXEMESTANE 25MG 10X10T G1 ACCORD GERMANY AS PER INVOICE	$100.0K	2
PHARMA DRUGS & MEDI EXEMESTANE TAB 25MG 3X10T G1(ACCORD-UK AS PER INVOICE	$98.4K	4

Intas Pharmaceuticals Limited exports 125 distinct Exemestane formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDI EXEMESTANE 25MG 10X1 with 13 shipments worth $396.1K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Exemestane Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED ★	$4.5M	260	21	$17.3K
4	MSN LABORATORIES PRIVATE LIMITED	$1.7M	34	1	$50.0K
2	EUGIA PHARMA SPECIALITIES LIMITED	$1.4M	27	1	$50.0K

Intas Pharmaceuticals Limited ranks #1 among 87 Indian Exemestane exporters. Average shipment value of $17.3K compared to the market average of $124.9K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.

Which Indian Ports Ship Exemestane Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	314	20.5%
DELHI AIR CARGO ACC (INDEL4)	273	17.8%
SAHAR AIR	256	16.7%
DELHI AIR	128	8.3%
Bombay Air Cargo	62	4.0%
MUNDRA SEA (INMUN1)	52	3.4%
MUNDRA SEA	51	3.3%
AHEMDABAD AIR ACC (INAMD4)	50	3.3%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Exemestane Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Exemestane shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 273 individual customs records matching Intas Pharmaceuticals Limited exporting Exemestane, covering 125 formulations to 21 countries via 40 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 57+ countries, 196+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Exemestane

Exemestane

Intas Pharmaceuticals Limited — Exemestane Exporter Profile

Intas Pharmaceuticals Limited — Exemestane Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Exemestane?

Who Are the Top Buyers of Exemestane from Intas Pharmaceuticals Limited?

What Is India's Total Exemestane Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Exemestane Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Exemestane Exporters?

What Exemestane Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Exemestane to Key Markets

Germany — BfArM/EMA

How Does Intas Pharmaceuticals Limited Compare to Nearest Exemestane Exporters?

Which Indian Ports Ship Exemestane Exports?

What Other Advanced Oncology Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Exemestane Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Exemestane Export Data from Intas Pharmaceuticals Limited

Exemestane Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source